BIOMAT Database Logo BIOMAT Database Logo

Cadmium inhibition of hepatic drug metabolism in the rat. 1974

W M Hadley, and T S Miya, and W F Bousquet

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D009574 Nitro Compounds Compounds having the nitro group, -NO2, attached to carbon. When attached to nitrogen they are nitramines and attached to oxygen they are NITRATES. Nitrated Compounds
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002104 Cadmium An element with atomic symbol Cd, atomic number 48, and atomic weight 112.41. It is a metal and ingestion will lead to CADMIUM POISONING.
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical

Related Publications

W M Hadley, and T S Miya, and W F Bousquet
Selenium antagonism of cadmium-induced inhibition of hepatic drug metabolism in the male rat.
March 1981, Toxicology and applied pharmacology,
W M Hadley, and T S Miya, and W F Bousquet
Cadmium inhibition of in vitro hepatic oxidative drug metabolism in the rat: comparison between ionic cadmium and cadmium-thionein.
February 1982, Research communications in chemical pathology and pharmacology,
W M Hadley, and T S Miya, and W F Bousquet
Studies on cadmium-induced inhibition of hepatic microsomal drug biotransformation in the rat.
February 1979, Environmental health perspectives,
W M Hadley, and T S Miya, and W F Bousquet
Cadmium-induced inhibition of hepatic drug biotransformation in the rat: effect of endocrine alterations.
October 1979, The Journal of pharmacology and experimental therapeutics,
W M Hadley, and T S Miya, and W F Bousquet
Inhibition of hepatic drug metabolism in the rat after Corynebacterium parvum treatment.
April 1983, Biochemical pharmacology,
W M Hadley, and T S Miya, and W F Bousquet
Inhibition of hepatic microsomal drug metabolism by atracurium administration in the rat.
September 1993, Pharmacology & toxicology,
W M Hadley, and T S Miya, and W F Bousquet
Inhibition of hepatic drug metabolizing enzyme by cadmium in mice.
April 1976, Bulletin of environmental contamination and toxicology,
W M Hadley, and T S Miya, and W F Bousquet
Inhibition of hepatic drug metabolism by norethindrone.
February 1979, Clinical pharmacology and therapeutics,
W M Hadley, and T S Miya, and W F Bousquet
Hepatic microsomal drug metabolism in the pregnant rat.
June 1982, Xenobiotica; the fate of foreign compounds in biological systems,
W M Hadley, and T S Miya, and W F Bousquet
MORPHINE INHIBITION OF DRUG METABOLISM IN THE RAT.
January 1964, Biochemical pharmacology,
Copied contents to your clipboard!